145 related articles for article (PubMed ID: 8706421)
21. [Exfoliative dermatitis caused by quinidine. Description of a clinical case].
Bellogini GC; Oneglia C
Minerva Cardioangiol; 1987 Sep; 35(9):457-9. PubMed ID: 2960915
[No Abstract] [Full Text] [Related]
22. Rifampin and exfoliative dermatitis.
Goldin HM; Schweitzer WJ; Bronson DM
Ann Intern Med; 1987 Nov; 107(5):789. PubMed ID: 2959187
[No Abstract] [Full Text] [Related]
23. Exfoliative dermatitis after clofazimine.
Pavithran K
Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):645-6. PubMed ID: 2935586
[No Abstract] [Full Text] [Related]
24. [Erythroderma caused by carbamazepine].
Granier F; Jay P; Mauduit G; Hermier C; Thivolet J
Rev Med Interne; 1987; 8(2):206-7. PubMed ID: 2954198
[No Abstract] [Full Text] [Related]
25. Severe exfoliative dermatitis caused by esomeprazole.
Mumoli N; Luschi R; Camaiti A; Cei M; Bagnoni G; Biondi A
J Am Geriatr Soc; 2011 Dec; 59(12):2377-8. PubMed ID: 22188084
[No Abstract] [Full Text] [Related]
26. Carbamazepine-associated exfoliative dermatitis.
Reed MD; Bertino JS; Blumer JL
Clin Pharm; 1982; 1(1):78-9. PubMed ID: 6223779
[No Abstract] [Full Text] [Related]
27. Exfoliative dermatitis related to omeprazole.
Epelde Gonzalo FD; Boada Montagut L; Tomás Vecina S
Ann Pharmacother; 1995 Jan; 29(1):82-3. PubMed ID: 7711353
[No Abstract] [Full Text] [Related]
28. Generalized pustulosis and severe tubulointerstitial nephropathy as manifestations of carbamazepine hypersensitivity syndrome.
Moreno-Ramírez D; García-Bravo B; Rodríguez-Pichardo A; Camacho CR; Martínez FC
Acta Derm Venereol; 2002; 82(5):374-6. PubMed ID: 12430739
[No Abstract] [Full Text] [Related]
29. Exfoliative dermatitis during cefoxitin therapy.
Kannangara DW; Smith B; Cohen K
Arch Intern Med; 1982 May; 142(5):1031-2. PubMed ID: 6211152
[TBL] [Abstract][Full Text] [Related]
30. Concurrence of palmoplantar psoriasiform eruptions and hair loss during carbamazepine treatment.
Oh SH; Kim DS; Kwon YS; Lee JH; Lee KH
Acta Derm Venereol; 2008; 88(5):532-3. PubMed ID: 18779906
[No Abstract] [Full Text] [Related]
31. Drug rash with eosinophilia and systemic symptoms (DRESS): changing carbamazepine to phenobarbital controlled epilepsy without the recurrence of DRESS.
Inadomi T
Eur J Dermatol; 2010; 20(2):220-2. PubMed ID: 20103499
[TBL] [Abstract][Full Text] [Related]
32. Nifedipine-induced exfoliative dermatitis and pedal edema.
Mohammed KN
Ann Pharmacother; 1994; 28(7-8):967. PubMed ID: 7949529
[No Abstract] [Full Text] [Related]
33. Exfoliative dermatitis during malarial prophylaxis with mefloquine.
Martin GJ; Malone JL; Ross EV
Clin Infect Dis; 1993 Feb; 16(2):341-2. PubMed ID: 8443327
[No Abstract] [Full Text] [Related]
34. Warfarin-induced erythroderma.
Rowe CJ; Robertson I; James D; McMeniman E
Australas J Dermatol; 2015 Feb; 56(1):e15-7. PubMed ID: 24592901
[TBL] [Abstract][Full Text] [Related]
35. Exfoliative dermatitis due ot carbamazepine (tegretol).
Ford GR; Bieder L
N Z Med J; 1968 Dec; 68(439):386-7. PubMed ID: 4236860
[No Abstract] [Full Text] [Related]
36. Patch test diagnosis of exfoliative dermatitis due to carbamazepine.
Camarasa JG
Contact Dermatitis; 1985 Jan; 12(1):49. PubMed ID: 3156718
[No Abstract] [Full Text] [Related]
37. HLA antigens in epileptic patients with drug-induced immunodeficiency.
Gilhus NE; Aarli JA; Thorsby E
Int J Immunopharmacol; 1982; 4(6):517-20. PubMed ID: 7152760
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous eruptions as part of the "anticonvulsant hypersensitivity syndrome".
Knowles SR; Shear NH
J Clin Psychopharmacol; 1996 Jun; 16(3):263-4. PubMed ID: 8784668
[No Abstract] [Full Text] [Related]
39. IgG2, IgG4 and IgA deficiency possibly associated with carbamazepine treatment.
Kato Z; Watanabe M; Kondo N
Eur J Pediatr; 2003 Mar; 162(3):209-211. PubMed ID: 12655433
[No Abstract] [Full Text] [Related]
40. Ketoconazole therapy and exfoliative erythroderma.
Rand R; Sober AJ; Olmstead PM
Arch Dermatol; 1983 Feb; 119(2):97-8. PubMed ID: 6297411
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
